Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNombre químico: N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-cyclohexylmethyl-L-tyrosine // Sinónimos: Fmoc-Tyr(CH2-Chx)-OH, Fmoc-Phe(4-OCH2-Chx)-OH, N-alpha-(9-Fluorenylmethyloxycarbonyl)-4-cyclohexylmethoxy-L-phenylalanine
from 100,00 €
This compound has been used to modify active peptides, in order to fill hydropohobic pockets and increase interactions. Peptides have been designed, which stabilize the CD4-bound conformation of gp120 leading to neutralized HIV entry in vitro and in vivo. It has been published that filling the subpocket at the JMJD2 active site, leads to inhibition of the JMJD2 subfamily of histone demethylases.
Interfacial Cavity Filling To Optimize CD4−Mimetic Miniprotein Interactions with HIV‑1 Surface Glycoprotein; Laurence Morellato-Castillo, Priyamvada Acharya, Olivier Combes, Johan Michiels, Anne Descours, Oscar H. P. Ramos, Yongping Yang, Guido Vanham, Kevin K. Ariën, Peter D. Kwong, Loïc Martin, and Pascal Kessler; J. Med. Chem. 2013; 56: 5033−5047. DOI: org/10.1021/jm4002988
Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches; Nathan R. Rose, Esther C. Y. Woon, Guy L. Kingham, Oliver N. F. King, Jasmin Mecinovic Ian J. Clifton, Stanley S. Ng, Jobina Talib-Hardy, Udo Oppermann, Michael A. McDonough, and Christopher J. Schofield; J. Med. Chem. 2010; 53: 1810–1818. DOI: 10.1021/jm901680b
Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors; Peng Cui, Jose L. Tomsig, William F. McCalmont, Sangderk Lee, Christopher J. Becker, Kevin R. Lynch and Timothy L. Macdonald; Bioorg Med. Chem. Lett. 2007; 17: 1634–1640; DOI: 10.1016/j.bmcl.2006.12.114
Por favor envíeme más información sobre